Patient Pathfinder: Clinical Trials
Clinical Trials for Esophageal Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 189 active Esophageal Cancer trials
Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors
Study Type: Interventional Phase 2
Lucid Registry Study
Study Type: Observational
Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer
Study Type: Interventional
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Study Type: Interventional Phase 3
Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal Cancer
Study Type: Interventional Phase 1
FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)
Study Type: Interventional Phase 1
A Study of CDX-585 in Patients With Advanced Malignancies
Study Type: Interventional Phase 1
Clinical Utility of Methylation-based Prognostic Assay for Barrett’s Esophagus
Study Type: Interventional
There are 189 active Esophageal Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now